DrugMapper


Display Options: Drug type Therapeutic Area Route of administration Mechanism of Action Indication Status		Total: 1404


Antibody Approved Unknown Unknown Bronchiolitis Obliterans Syndrome; Leukemia, Prolymphocytic; Lymphoma, B-Cell; Neuromyelitis Optica; Acquired Immunodeficiency Syndrome; Burkitt Lymphoma; Hodgkin Disease; Leukemia, Lymphoid; Lymphoma; Lymphoma, Mantle-Cell; Melanoma; Nephrotic Syndrome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Waldenstrom Macroglobulinemia; Arthritis, Rheumatoid; Leukemia; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Pemphigus; Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Neoplasms B-lymphocyte antigen CD20 binding agent

Antibody

Approved

Unknown

Bronchiolitis Obliterans Syndrome; Leukemia, Prolymphocytic; Lymphoma, B-Cell; Neuromyelitis Optica; Acquired Immunodeficiency Syndrome; Burkitt Lymphoma; Hodgkin Disease; Leukemia, Lymphoid; Lymphoma; Lymphoma, Mantle-Cell; Melanoma; Nephrotic Syndrome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Waldenstrom Macroglobulinemia; Arthritis, Rheumatoid; Leukemia; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Pemphigus; Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Neoplasms

B-lymphocyte antigen CD20 binding agent


Antibody Approved RHEUMATOLOGY SUBCUTANEOUS Breast Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Macular Degeneration; Myelodysplastic Syndromes; Pulmonary Disease, Chronic Obstructive; Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Rheumatoid; Atrial Fibrillation; Behcet Syndrome; Chronic Urticaria; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dry Eye Syndromes; Hepatitis, Alcoholic; Melanoma; Mucocutaneous Lymph Node Syndrome; Osteoarthritis; Osteoarthritis, Knee; Peripheral Arterial Disease; Polymyalgia Rheumatica; Pyoderma; Sarcoidosis, Pulmonary; Schnitzler Syndrome; Atherosclerosis; Carcinoma, Non-Small-Cell Lung; Fever; Gout; Hypoglycemia; Lung Neoplasms; Pancreatic Neoplasms; Pneumonia; Severe Acute Respiratory Syndrome; Still's Disease, Adult-Onset; Systemic Inflammatory Response Syndrome; Arthritis, Gouty; Arthritis, Juvenile; Cryopyrin-Associated Periodic Syndromes; Familial Mediterranean Fever; Immune System Diseases; Mevalonate Kinase Deficiency Interleukin-1 beta inhibitor

Antibody

Approved

RHEUMATOLOGY

SUBCUTANEOUS

Breast Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Macular Degeneration; Myelodysplastic Syndromes; Pulmonary Disease, Chronic Obstructive; Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Rheumatoid; Atrial Fibrillation; Behcet Syndrome; Chronic Urticaria; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dry Eye Syndromes; Hepatitis, Alcoholic; Melanoma; Mucocutaneous Lymph Node Syndrome; Osteoarthritis; Osteoarthritis, Knee; Peripheral Arterial Disease; Polymyalgia Rheumatica; Pyoderma; Sarcoidosis, Pulmonary; Schnitzler Syndrome; Atherosclerosis; Carcinoma, Non-Small-Cell Lung; Fever; Gout; Hypoglycemia; Lung Neoplasms; Pancreatic Neoplasms; Pneumonia; Severe Acute Respiratory Syndrome; Still's Disease, Adult-Onset; Systemic Inflammatory Response Syndrome; Arthritis, Gouty; Arthritis, Juvenile; Cryopyrin-Associated Periodic Syndromes; Familial Mediterranean Fever; Immune System Diseases; Mevalonate Kinase Deficiency

Interleukin-1 beta inhibitor


Antibody Approved MUSCULOSKELETAL; PREGNANCY AND GYNECOLOGY SUBCUTANEOUS Crohn Disease; Kidney Diseases; Ovarian Neoplasms; Aortic Valve Stenosis; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Fibrous Dysplasia of Bone; Gout; Histiocytosis, Langerhans-Cell; Hypersensitivity; Infertility, Male; Inflammatory Breast Neoplasms; Melanoma; Multiple Myeloma; Neoplasms; Osteoarthritis, Hip; Osteolysis; Osteosarcoma; Thyroid Neoplasms; Anorexia Nervosa; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma; Carcinoma, Renal Cell; Diabetes Mellitus; Fractures, Bone; Lung Neoplasms; Osteogenesis Imperfecta; Prostatic Neoplasms, Castration-Resistant; Bone Diseases; Bone Resorption; Breast Neoplasms; Giant Cell Tumor of Bone; Giant Cell Tumors; Hypercalcemia; Neoplasm Metastasis; Neoplasms, Bone Tissue; Osteoporosis; Osteoporosis, Postmenopausal Tumor necrosis factor ligand superfamily member 11 inhibitor

Antibody

Approved

MUSCULOSKELETAL; PREGNANCY AND GYNECOLOGY

SUBCUTANEOUS

Crohn Disease; Kidney Diseases; Ovarian Neoplasms; Aortic Valve Stenosis; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Fibrous Dysplasia of Bone; Gout; Histiocytosis, Langerhans-Cell; Hypersensitivity; Infertility, Male; Inflammatory Breast Neoplasms; Melanoma; Multiple Myeloma; Neoplasms; Osteoarthritis, Hip; Osteolysis; Osteosarcoma; Thyroid Neoplasms; Anorexia Nervosa; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma; Carcinoma, Renal Cell; Diabetes Mellitus; Fractures, Bone; Lung Neoplasms; Osteogenesis Imperfecta; Prostatic Neoplasms, Castration-Resistant; Bone Diseases; Bone Resorption; Breast Neoplasms; Giant Cell Tumor of Bone; Giant Cell Tumors; Hypercalcemia; Neoplasm Metastasis; Neoplasms, Bone Tissue; Osteoporosis; Osteoporosis, Postmenopausal

Tumor necrosis factor ligand superfamily member 11 inhibitor


Antibody Approved DERMATOLOGY INJECTION Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Endometrial Neoplasms; Fallopian Tube Neoplasms; Glioma; HIV Infections; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasm Metastasis; Nerve Sheath Neoplasms; Neuroblastoma; Peritoneal Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retroperitoneal Neoplasms; Skin Neoplasms; Triple Negative Breast Neoplasms; Adenocarcinoma; Adenocarcinoma of Lung; Basal Cell Nevus Syndrome; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoid Tumor; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Colonic Neoplasms; Esophageal Neoplasms; Gastrointestinal Stromal Tumors; Gliosarcoma; Histiocytoma, Malignant Fibrous; Hodgkin Disease; Inflammatory Breast Neoplasms; Leiomyosarcoma; Liposarcoma; Meningioma; Nasopharyngeal Carcinoma; Neuroendocrine Tumors; Ovarian Neoplasms; Pancreatic Neoplasms; Pituitary Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Retroviridae Infections; Salivary Gland Neoplasms; Sarcoma, Kaposi; Sarcoma, Synovial; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Uveal Melanoma; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Glioblastoma; Head and Neck Neoplasms; Kidney Neoplasms; Lung Neoplasms; Mesothelioma; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Small Cell Lung Carcinoma; Stomach Neoplasms; Urogenital Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Melanoma; Mesothelioma, Malignant; Neoplasms Cytotoxic T-lymphocyte protein 4 inhibitor

Antibody

Approved

DERMATOLOGY

INJECTION

Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Endometrial Neoplasms; Fallopian Tube Neoplasms; Glioma; HIV Infections; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasm Metastasis; Nerve Sheath Neoplasms; Neuroblastoma; Peritoneal Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retroperitoneal Neoplasms; Skin Neoplasms; Triple Negative Breast Neoplasms; Adenocarcinoma; Adenocarcinoma of Lung; Basal Cell Nevus Syndrome; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoid Tumor; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Colonic Neoplasms; Esophageal Neoplasms; Gastrointestinal Stromal Tumors; Gliosarcoma; Histiocytoma, Malignant Fibrous; Hodgkin Disease; Inflammatory Breast Neoplasms; Leiomyosarcoma; Liposarcoma; Meningioma; Nasopharyngeal Carcinoma; Neuroendocrine Tumors; Ovarian Neoplasms; Pancreatic Neoplasms; Pituitary Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Retroviridae Infections; Salivary Gland Neoplasms; Sarcoma, Kaposi; Sarcoma, Synovial; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Uveal Melanoma; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Glioblastoma; Head and Neck Neoplasms; Kidney Neoplasms; Lung Neoplasms; Mesothelioma; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Small Cell Lung Carcinoma; Stomach Neoplasms; Urogenital Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Melanoma; Mesothelioma, Malignant; Neoplasms

Cytotoxic T-lymphocyte protein 4 inhibitor


Antibody Approved CANCER; OTHER INJECTION Hematologic Neoplasms; HIV Infections; Leukemia; Leukemia, Myeloid, Acute; Enteropathy-Associated T-Cell Lymphoma; Graft vs Host Disease; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Mast-Cell; Lupus Erythematosus, Systemic; Lymphoma, Follicular; Lymphoma, T-Cell, Peripheral; Mastocytosis, Systemic; Mesothelioma, Malignant; Neoplasms, Germ Cell and Embryonal; Scleroderma, Diffuse; Sezary Syndrome; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Hodgkin Disease; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Neoplasms Tubulin inhibitor

Antibody

Approved

CANCER; OTHER

INJECTION

Hematologic Neoplasms; HIV Infections; Leukemia; Leukemia, Myeloid, Acute; Enteropathy-Associated T-Cell Lymphoma; Graft vs Host Disease; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Mast-Cell; Lupus Erythematosus, Systemic; Lymphoma, Follicular; Lymphoma, T-Cell, Peripheral; Mastocytosis, Systemic; Mesothelioma, Malignant; Neoplasms, Germ Cell and Embryonal; Scleroderma, Diffuse; Sezary Syndrome; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Hodgkin Disease; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Neoplasms

Tubulin inhibitor


Antibody Approved Unknown Unknown Graft vs Host Disease; Lymphopenia; Neuromyelitis Optica; Arthritis, Rheumatoid; Emphysema; Glomerulonephritis, Membranous; Kidney Diseases; Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Sclerosis; Myositis; Nephrotic Syndrome; Polyendocrinopathies, Autoimmune; Scleroderma, Systemic; Sjogren's Syndrome; Purpura, Thrombocytopenic, Idiopathic; Vasculitis; Lupus Erythematosus, Systemic; Lupus Nephritis Tumor necrosis factor ligand superfamily member 13B inhibitor

Antibody

Approved

Unknown

Graft vs Host Disease; Lymphopenia; Neuromyelitis Optica; Arthritis, Rheumatoid; Emphysema; Glomerulonephritis, Membranous; Kidney Diseases; Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Sclerosis; Myositis; Nephrotic Syndrome; Polyendocrinopathies, Autoimmune; Scleroderma, Systemic; Sjogren's Syndrome; Purpura, Thrombocytopenic, Idiopathic; Vasculitis; Lupus Erythematosus, Systemic; Lupus Nephritis

Tumor necrosis factor ligand superfamily member 13B inhibitor


Antibody Approved PREGNANCY AND GYNECOLOGY SINGLE-USE Breast Diseases; Breast Neoplasms, Male; Colonic Neoplasms; Rectal Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Fallopian Tube Neoplasms; Hemangiosarcoma; Hematologic Neoplasms; Neoplasm Metastasis; Pancreatic Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Esophageal Neoplasms; Inflammatory Breast Neoplasms; Ovarian Neoplasms; Stomach Neoplasms; Breast Neoplasms; Neoplasms Receptor protein-tyrosine kinase erbB-2 inhibitor

Antibody

Approved

PREGNANCY AND GYNECOLOGY

SINGLE-USE

Breast Diseases; Breast Neoplasms, Male; Colonic Neoplasms; Rectal Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Fallopian Tube Neoplasms; Hemangiosarcoma; Hematologic Neoplasms; Neoplasm Metastasis; Pancreatic Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Esophageal Neoplasms; Inflammatory Breast Neoplasms; Ovarian Neoplasms; Stomach Neoplasms; Breast Neoplasms; Neoplasms

Receptor protein-tyrosine kinase erbB-2 inhibitor


Antibody Approved OTHER IV (INFUSION) Anthrax Protective antigen binding agent


Antibody Approved Unknown Unknown Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung; Multiple Myeloma; Neoplasm Metastasis; Salivary Gland Neoplasms; Stomach Neoplasms; Inflammatory Breast Neoplasms; Breast Neoplasms; Neoplasms Receptor protein-tyrosine kinase erbB-2 binding agent


Antibody Approved CANCER INJECTION Burkitt Lymphoma; Colorectal Neoplasms; Hodgkin Disease; Kidney Failure, Chronic; Leukemia, Prolymphocytic; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Graft vs Host Disease; Leukemia; Leukemia, Hairy Cell; Leukemia, Lymphoid; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Mantle-Cell; Nephrotic Syndrome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Purpura, Thrombocytopenic, Idiopathic; Waldenstrom Macroglobulinemia; Kidney Diseases; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Neoplasms B-lymphocyte antigen CD20 binding agent

Antibody

Approved

CANCER

INJECTION

Burkitt Lymphoma; Colorectal Neoplasms; Hodgkin Disease; Kidney Failure, Chronic; Leukemia, Prolymphocytic; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Graft vs Host Disease; Leukemia; Leukemia, Hairy Cell; Leukemia, Lymphoid; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Mantle-Cell; Nephrotic Syndrome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Purpura, Thrombocytopenic, Idiopathic; Waldenstrom Macroglobulinemia; Kidney Diseases; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Neoplasms

B-lymphocyte antigen CD20 binding agent


Antibody Approved DERMATOLOGY UNKNOWN Astrocytoma; Bile Duct Neoplasms; Carcinoma, Basal Cell; Carcinoma, Intraductal, Noninfiltrating; Glioma; Histiocytoma, Malignant Fibrous; HIV Infections; Leukemia; Leukemia, Biphenotypic, Acute; Leukemia, Lymphoid; Lymphoma, Mantle-Cell; Lymphoma, T-Cell, Cutaneous; Neuroblastoma; Papillomavirus Infections; Rhabdomyosarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Smoldering Multiple Myeloma; Uterine Neoplasms; Adenocarcinoma; Adenocarcinoma, Follicular; Adrenal Cortex Neoplasms; Anus Neoplasms; Breast Neoplasms, Male; Carcinoid Tumor; Carcinoma, Adenoid Cystic; Carcinoma in Situ; Carcinoma, Medullary; Carcinoma, Neuroendocrine; Carcinoma, Pancreatic Ductal; Carcinosarcoma; Cholangiocarcinoma; Colonic Neoplasms; Fallopian Tube Neoplasms; Gallbladder Neoplasms; Gastrointestinal Stromal Tumors; Genital Neoplasms, Female; Gestational Trophoblastic Disease; Glioblastoma; Gliosarcoma; Granuloma, Lethal Midline; Hemangiosarcoma; Hematologic Neoplasms; Hereditary Breast and Ovarian Cancer Syndrome; Inflammatory Breast Neoplasms; Kidney Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Leukoencephalopathy, Progressive Multifocal; Leukoplakia, Oral; Liver Neoplasms; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Meningeal Carcinomatosis; Meningeal Neoplasms; Meningioma; Mouth Neoplasms; Mycosis Fungoides; Myelodysplastic Syndromes; Nasopharyngeal Carcinoma; Neoplasm Metastasis; Neurilemmoma; Neuroendocrine Tumors; Oropharyngeal Neoplasms; Osteosarcoma; Ovarian Neoplasms; Pancreatic Neoplasms; Papilloma; Paraganglioma; Parotid Neoplasms; Penile Neoplasms; Peritoneal Neoplasms; Pneumonia, Viral; Rectal Neoplasms; Retroviridae Infections; Salivary Gland Neoplasms; Sarcoma; Sarcoma, Alveolar Soft Part; Sarcoma, Kaposi; Severe Acute Respiratory Syndrome; Sezary Syndrome; Skin Neoplasms; Thymoma; Thymus Neoplasms; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Uveal Melanoma; Vulvar Neoplasms; Waldenstrom Macroglobulinemia; Adenocarcinoma of Lung; Biliary Tract Neoplasms; Brain Neoplasms; Breast Carcinoma In Situ; Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Merkel Cell; Colorectal Neoplasms; Esophageal Neoplasms; Head and Neck Neoplasms; Lung Neoplasms; Mesothelioma; Multiple Myeloma; Nasopharyngeal Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Small Cell Lung Carcinoma; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Endometrial Neoplasms; Hodgkin Disease; Melanoma; Neoplasms; Squamous Cell Carcinoma of Head and Neck Programmed cell death protein 1 inhibitor

Antibody

Approved

DERMATOLOGY

UNKNOWN

Astrocytoma; Bile Duct Neoplasms; Carcinoma, Basal Cell; Carcinoma, Intraductal, Noninfiltrating; Glioma; Histiocytoma, Malignant Fibrous; HIV Infections; Leukemia; Leukemia, Biphenotypic, Acute; Leukemia, Lymphoid; Lymphoma, Mantle-Cell; Lymphoma, T-Cell, Cutaneous; Neuroblastoma; Papillomavirus Infections; Rhabdomyosarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Smoldering Multiple Myeloma; Uterine Neoplasms; Adenocarcinoma; Adenocarcinoma, Follicular; Adrenal Cortex Neoplasms; Anus Neoplasms; Breast Neoplasms, Male; Carcinoid Tumor; Carcinoma, Adenoid Cystic; Carcinoma in Situ; Carcinoma, Medullary; Carcinoma, Neuroendocrine; Carcinoma, Pancreatic Ductal; Carcinosarcoma; Cholangiocarcinoma; Colonic Neoplasms; Fallopian Tube Neoplasms; Gallbladder Neoplasms; Gastrointestinal Stromal Tumors; Genital Neoplasms, Female; Gestational Trophoblastic Disease; Glioblastoma; Gliosarcoma; Granuloma, Lethal Midline; Hemangiosarcoma; Hematologic Neoplasms; Hereditary Breast and Ovarian Cancer Syndrome; Inflammatory Breast Neoplasms; Kidney Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Leukoencephalopathy, Progressive Multifocal; Leukoplakia, Oral; Liver Neoplasms; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Meningeal Carcinomatosis; Meningeal Neoplasms; Meningioma; Mouth Neoplasms; Mycosis Fungoides; Myelodysplastic Syndromes; Nasopharyngeal Carcinoma; Neoplasm Metastasis; Neurilemmoma; Neuroendocrine Tumors; Oropharyngeal Neoplasms; Osteosarcoma; Ovarian Neoplasms; Pancreatic Neoplasms; Papilloma; Paraganglioma; Parotid Neoplasms; Penile Neoplasms; Peritoneal Neoplasms; Pneumonia, Viral; Rectal Neoplasms; Retroviridae Infections; Salivary Gland Neoplasms; Sarcoma; Sarcoma, Alveolar Soft Part; Sarcoma, Kaposi; Severe Acute Respiratory Syndrome; Sezary Syndrome; Skin Neoplasms; Thymoma; Thymus Neoplasms; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Uveal Melanoma; Vulvar Neoplasms; Waldenstrom Macroglobulinemia; Adenocarcinoma of Lung; Biliary Tract Neoplasms; Brain Neoplasms; Breast Carcinoma In Situ; Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Merkel Cell; Colorectal Neoplasms; Esophageal Neoplasms; Head and Neck Neoplasms; Lung Neoplasms; Mesothelioma; Multiple Myeloma; Nasopharyngeal Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Small Cell Lung Carcinoma; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Endometrial Neoplasms; Hodgkin Disease; Melanoma; Neoplasms; Squamous Cell Carcinoma of Head and Neck

Programmed cell death protein 1 inhibitor


Antibody Approved CANCER INJECTION Burkitt Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Multiple Myeloma; Hematologic Neoplasms; Leukemia, Biphenotypic, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Leukemia; Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma B-lymphocyte antigen CD19 cross-linking agent


Antibody Approved IMMUNE SYSTEM; OTHER INJECTION Carcinoma, Renal Cell; Diabetes Mellitus, Type 1; Leukemia; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Paraproteinemias; Schizophrenia; Kidney Neoplasms; Myelodysplastic Syndromes; Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Multiple Myeloma; Severe Acute Respiratory Syndrome; Castleman Disease; Immune System Diseases Interleukin-6 antagonist

Antibody

Approved

IMMUNE SYSTEM; OTHER

INJECTION

Carcinoma, Renal Cell; Diabetes Mellitus, Type 1; Leukemia; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Paraproteinemias; Schizophrenia; Kidney Neoplasms; Myelodysplastic Syndromes; Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Multiple Myeloma; Severe Acute Respiratory Syndrome; Castleman Disease; Immune System Diseases

Interleukin-6 antagonist


Antibody Approved GASTROINTESTINAL; OTHER INJECTION Desmoplastic Small Round Cell Tumor; Glioma; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Sarcoma, Synovial; Adenocarcinoma; Biliary Tract Neoplasms; Carcinoid Tumor; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Cholangiocarcinoma; Colonic Neoplasms; Esophageal Neoplasms; Gallbladder Neoplasms; Glioblastoma; Head and Neck Neoplasms; Lung Neoplasms; Melanoma; Mesothelioma; Mesothelioma, Malignant; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Thymoma; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms; Stomach Neoplasms Vascular endothelial growth factor receptor 2 inhibitor

Antibody

Approved

GASTROINTESTINAL; OTHER

INJECTION

Desmoplastic Small Round Cell Tumor; Glioma; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Sarcoma, Synovial; Adenocarcinoma; Biliary Tract Neoplasms; Carcinoid Tumor; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Cholangiocarcinoma; Colonic Neoplasms; Esophageal Neoplasms; Gallbladder Neoplasms; Glioblastoma; Head and Neck Neoplasms; Lung Neoplasms; Melanoma; Mesothelioma; Mesothelioma, Malignant; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Thymoma; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms; Stomach Neoplasms

Vascular endothelial growth factor receptor 2 inhibitor


Antibody Approved GASTROINTESTINAL INJECTION Diabetes Mellitus, Type 1; Inflammatory Bowel Diseases; Melanoma; Celiac Disease; Colitis; HIV Infections; Infections; Neoplasms; Salivary Gland Neoplasms; Pouchitis; Colitis, Ulcerative; Crohn Disease Integrin alpha-4/beta-7 inhibitor


Antibody Approved Unknown INJECTION Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Glioblastoma; Carcinoma, Renal Cell; Heart Failure; Lung Neoplasms; Sepsis; ST Elevation Myocardial Infarction; Acute Coronary Syndrome; Hyperlipidemia, Familial Combined; Hyperlipidemias; Lipid Metabolism Disorders; Severe Acute Respiratory Syndrome; Cardiovascular Diseases; Coronary Artery Disease; Dyslipidemias; Hypercholesterolemia; Hyperlipoproteinemia Type II; Myocardial Infarction; Stroke Subtilisin/kexin type 9 inhibitor

Antibody

Approved

Unknown

INJECTION

Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Glioblastoma; Carcinoma, Renal Cell; Heart Failure; Lung Neoplasms; Sepsis; ST Elevation Myocardial Infarction; Acute Coronary Syndrome; Hyperlipidemia, Familial Combined; Hyperlipidemias; Lipid Metabolism Disorders; Severe Acute Respiratory Syndrome; Cardiovascular Diseases; Coronary Artery Disease; Dyslipidemias; Hypercholesterolemia; Hyperlipoproteinemia Type II; Myocardial Infarction; Stroke

Subtilisin/kexin type 9 inhibitor


Antibody Approved Unknown INJECTION Amyloidosis, Familial; Hematologic Neoplasms; Immunoglobulin G4-Related Disease; Leukemia, Plasma Cell; Smoldering Multiple Myeloma; Multiple Myeloma; Neoplasms SLAM family member 7 inhibitor


Antibody Approved Unknown INTRA-ARTICULAR; INTRAMUSCULAR; INTRAVITREAL Lung Neoplasms; Neoplasm Metastasis; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung; Neoplasms Epidermal growth factor receptor erbB1 inhibitor


Antibody Approved Unknown INTRAVENOUS Leiomyosarcoma; Osteosarcoma; Small Cell Lung Carcinoma; Ganglioneuroblastoma; Neoplasms; Neuroblastoma Disialoganglioside GD2 binding agent


Antibody Approved Unknown INJECTION Sepsis; Nephrotic Syndrome; Diabetes Mellitus; Hypercholesterolemia; Lipid Metabolism Disorders; Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Dyslipidemias; Hyperlipoproteinemia Type II Subtilisin/kexin type 9 inhibitor


Antibody Approved Unknown INJECTION Hemorrhage Dabigatran sequestering agent


Antibody Approved RESPIRATORY INJECTION Diffuse Intrinsic Pontine Glioma; Fallopian Tube Neoplasms; Genital Neoplasms, Female; Hepatitis C; Hepatitis D; HIV Infections; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Neoplasm Metastasis; Nerve Sheath Neoplasms; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retroperitoneal Neoplasms; Rhabdomyosarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Sepsis; Sezary Syndrome; ST Elevation Myocardial Infarction; Triple Negative Breast Neoplasms; Adrenal Cortex Neoplasms; Basal Cell Nevus Syndrome; Biliary Tract Neoplasms; Carcinoid Tumor; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Large Cell; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Carcinoma, Pancreatic Ductal; Carcinoma, Small Cell; Carcinosarcoma; Cell- and Tissue-Based Therapy; Cholangiocarcinoma; Chordoma; Colonic Neoplasms; Craniopharyngioma; Endometrial Neoplasms; Gastrointestinal Stromal Tumors; Glioma; Gliosarcoma; Hematologic Neoplasms; Hepatitis B, Chronic; Histiocytoma, Malignant Fibrous; Inflammatory Breast Neoplasms; Leiomyosarcoma; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Leukoplakia, Oral; Liposarcoma; Liver Neoplasms; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Meningioma; Mesothelioma, Malignant; Myelodysplastic Syndromes; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neuroendocrine Tumors; Oligodendroglioma; Oropharyngeal Neoplasms; Osteosarcoma; Ovarian Neoplasms; Pancreatic Neoplasms; Paraganglioma; Peritoneal Neoplasms; Pituitary Neoplasms; Pneumonia, Viral; Prostatic Neoplasms; Pulmonary Disease, Chronic Obstructive; Rectal Neoplasms; Retroviridae Infections; Salivary Gland Neoplasms; Sarcoma, Kaposi; Severe Acute Respiratory Syndrome; Small Cell Lung Carcinoma; Thyroid Neoplasms; Uterine Cervical Neoplasms; Uveal Melanoma; Adenocarcinoma; Adenocarcinoma of Lung; Brain Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Esophageal Neoplasms; Glioblastoma; Head and Neck Neoplasms; Kidney Neoplasms; Lung Neoplasms; Lymphoma; Multiple Myeloma; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Skin Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Colorectal Neoplasms; Hodgkin Disease; Melanoma; Mesothelioma; Neoplasms; Squamous Cell Carcinoma of Head and Neck Programmed cell death protein 1 inhibitor

Antibody

Approved

RESPIRATORY

INJECTION

Diffuse Intrinsic Pontine Glioma; Fallopian Tube Neoplasms; Genital Neoplasms, Female; Hepatitis C; Hepatitis D; HIV Infections; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Neoplasm Metastasis; Nerve Sheath Neoplasms; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retroperitoneal Neoplasms; Rhabdomyosarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Sepsis; Sezary Syndrome; ST Elevation Myocardial Infarction; Triple Negative Breast Neoplasms; Adrenal Cortex Neoplasms; Basal Cell Nevus Syndrome; Biliary Tract Neoplasms; Carcinoid Tumor; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Large Cell; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Carcinoma, Pancreatic Ductal; Carcinoma, Small Cell; Carcinosarcoma; Cell- and Tissue-Based Therapy; Cholangiocarcinoma; Chordoma; Colonic Neoplasms; Craniopharyngioma; Endometrial Neoplasms; Gastrointestinal Stromal Tumors; Glioma; Gliosarcoma; Hematologic Neoplasms; Hepatitis B, Chronic; Histiocytoma, Malignant Fibrous; Inflammatory Breast Neoplasms; Leiomyosarcoma; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Leukoplakia, Oral; Liposarcoma; Liver Neoplasms; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Meningioma; Mesothelioma, Malignant; Myelodysplastic Syndromes; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neuroendocrine Tumors; Oligodendroglioma; Oropharyngeal Neoplasms; Osteosarcoma; Ovarian Neoplasms; Pancreatic Neoplasms; Paraganglioma; Peritoneal Neoplasms; Pituitary Neoplasms; Pneumonia, Viral; Prostatic Neoplasms; Pulmonary Disease, Chronic Obstructive; Rectal Neoplasms; Retroviridae Infections; Salivary Gland Neoplasms; Sarcoma, Kaposi; Severe Acute Respiratory Syndrome; Small Cell Lung Carcinoma; Thyroid Neoplasms; Uterine Cervical Neoplasms; Uveal Melanoma; Adenocarcinoma; Adenocarcinoma of Lung; Brain Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Esophageal Neoplasms; Glioblastoma; Head and Neck Neoplasms; Kidney Neoplasms; Lung Neoplasms; Lymphoma; Multiple Myeloma; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Skin Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Colorectal Neoplasms; Hodgkin Disease; Melanoma; Mesothelioma; Neoplasms; Squamous Cell Carcinoma of Head and Neck

Programmed cell death protein 1 inhibitor


Antibody Approved IMMUNE SYSTEM INJECTION Pityriasis Rubra Pilaris; Rosacea; Alopecia Areata; Asthma; Crohn Disease; Dermatitis, Atopic; Diabetes Mellitus, Type 1; Dry Eye Syndromes; Inflammatory Bowel Diseases; Lichen Planus; Lupus Erythematosus, Discoid; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Necrobiosis Lipoidica; Pyoderma; Severe Acute Respiratory Syndrome; Arthritis, Rheumatoid; Behcet Syndrome; Giant Cell Arteritis; Graves Ophthalmopathy; Hidradenitis Suppurativa; Lupus Nephritis; Osteoarthritis; Polymyalgia Rheumatica; Tendinopathy; Uveitis; Arthritis, Psoriatic; Immune System Diseases; Psoriasis; Spondylarthropathies; Spondylitis, Ankylosing Interleukin 17A inhibitor

Antibody

Approved

IMMUNE SYSTEM

INJECTION

Pityriasis Rubra Pilaris; Rosacea; Alopecia Areata; Asthma; Crohn Disease; Dermatitis, Atopic; Diabetes Mellitus, Type 1; Dry Eye Syndromes; Inflammatory Bowel Diseases; Lichen Planus; Lupus Erythematosus, Discoid; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Necrobiosis Lipoidica; Pyoderma; Severe Acute Respiratory Syndrome; Arthritis, Rheumatoid; Behcet Syndrome; Giant Cell Arteritis; Graves Ophthalmopathy; Hidradenitis Suppurativa; Lupus Nephritis; Osteoarthritis; Polymyalgia Rheumatica; Tendinopathy; Uveitis; Arthritis, Psoriatic; Immune System Diseases; Psoriasis; Spondylarthropathies; Spondylitis, Ankylosing

Interleukin 17A inhibitor


Antibody Approved Unknown Unknown Chronic Urticaria; Eosinophilia; Eosinophilic Esophagitis; Churg-Strauss Syndrome; Granulomatosis with Polyangiitis; Nasal Polyps; Pulmonary Disease, Chronic Obstructive; Asthma; Chronic Disease; Hypereosinophilic Syndrome; Lung Diseases, Obstructive; Systemic Vasculitis Interleukin-5 inhibitor


Antibody Approved Unknown INJECTION Anemia, Aplastic; Anemia, Hemolytic; Carcinoma, Renal Cell; Glioblastoma; Graft vs Host Disease; Hodgkin Disease; Immune System Diseases; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Prostatic Neoplasms; Alzheimer Disease; Anemia, Sickle Cell; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Genital Neoplasms, Male; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Leukemia; Leukemia, Biphenotypic, Acute; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukemia, Plasma Cell; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Myelodysplastic Syndromes; Nephrotic Syndrome; Neuromyelitis Optica; Paraproteinemias; Plasmacytoma; POEMS Syndrome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms, Castration-Resistant; Purpura, Thrombocytopenic, Idiopathic; Waldenstrom Macroglobulinemia; Amyloidosis; Amyloidosis, Familial; Smoldering Multiple Myeloma; Multiple Myeloma; Neoplasms Lymphocyte differentiation antigen CD38 inhibitor

Antibody

Approved

Unknown

INJECTION

Anemia, Aplastic; Anemia, Hemolytic; Carcinoma, Renal Cell; Glioblastoma; Graft vs Host Disease; Hodgkin Disease; Immune System Diseases; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Prostatic Neoplasms; Alzheimer Disease; Anemia, Sickle Cell; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Genital Neoplasms, Male; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Leukemia; Leukemia, Biphenotypic, Acute; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukemia, Plasma Cell; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Myelodysplastic Syndromes; Nephrotic Syndrome; Neuromyelitis Optica; Paraproteinemias; Plasmacytoma; POEMS Syndrome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms, Castration-Resistant; Purpura, Thrombocytopenic, Idiopathic; Waldenstrom Macroglobulinemia; Amyloidosis; Amyloidosis, Familial; Smoldering Multiple Myeloma; Multiple Myeloma; Neoplasms

Lymphocyte differentiation antigen CD38 inhibitor


Antibody Approved Unknown INJECTION Lichen Planus; Arthritis, Rheumatoid; Constriction, Pathologic; Depressive Disorder, Major; Diabetes Mellitus, Type 1; Guttate Psoriasis; Pemphigoid, Bullous; Pityriasis Rubra Pilaris; Pyoderma; Severe Acute Respiratory Syndrome; Spondylitis, Ankylosing; Arthritis, Psoriatic; Immune System Diseases; Psoriasis Interleukin 17A inhibitor

Antibody

Approved

Unknown

INJECTION

Adenocarcinoma; Glioma; Gliosarcoma; Idiopathic Pulmonary Fibrosis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Multiple Myeloma; Myelodysplastic Syndromes; Paraganglioma; Rhabdomyosarcoma; Skin Neoplasms; Adrenal Cortex Neoplasms; Anus Neoplasms; Astrocytoma; Biliary Tract Neoplasms; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colonic Neoplasms; Gallbladder Neoplasms; Gastrointestinal Stromal Tumors; Glioblastoma; Head and Neck Neoplasms; Hematologic Neoplasms; Hodgkin Disease; Kidney Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Liver Neoplasms; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Neoplasm Metastasis; Oropharyngeal Neoplasms; Osteosarcoma; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Retroviridae Infections; Sarcoma; Sarcoma, Alveolar Soft Part; Sezary Syndrome; Stomach Neoplasms; Thyroid Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Fallopian Tube Neoplasms; Melanoma; Mesothelioma; Ovarian Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Uterine Cervical Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Lung Neoplasms; Neoplasms; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Urologic Neoplasms

Programmed cell death 1 ligand 1 inhibitor


Antibody Approved Unknown INJECTION Infections; Clostridium Infections; Enterocolitis, Pseudomembranous Toxin B inhibitor


Antibody Approved Unknown INJECTION Bronchitis; Hypereosinophilic Syndrome; Loiasis; Eosinophilic Esophagitis; Sinusitis; Substance-Related Disorders; Asthma; Lung Diseases, Obstructive Interleukin-5 inhibitor


Antibody Approved Unknown INJECTION Leiomyosarcoma; Neoplasm Metastasis; Pancreatic Neoplasms; Carcinoma, Non-Small-Cell Lung; Gastrointestinal Stromal Tumors; Glioblastoma; Ovarian Neoplasms; Prostatic Neoplasms, Castration-Resistant; Neoplasms; Sarcoma Platelet-derived growth factor receptor alpha antagonist


Antibody Approved Unknown INJECTION Anthrax Protective antigen binding agent


Antibody Approved Unknown UNKNOWN Blast Crisis; Burkitt Lymphoma; Leukemia, Biphenotypic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hematologic Neoplasms; Leukemia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma CD22 binding agent


Antibody Approved Unknown INJECTION Hemophilia A; Hemorrhage Coagulation factor IX and X other

Antibody

Approved

Unknown

INJECTION; INTRAVENOUS

Carcinoma, Pancreatic Ductal; Central Nervous System Neoplasms; Chordoma; Fallopian Tube Neoplasms; Glioma; Head and Neck Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Melanoma; Meningioma; Mesothelioma; Peritoneal Neoplasms; Primary Myelofibrosis; Prostatic Neoplasms; Uveal Melanoma; Adenocarcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Gestational Trophoblastic Disease; Glioblastoma; Hemangiosarcoma; Hodgkin Disease; Kidney Neoplasms; Leiomyosarcoma; Lymphoma; Multiple Myeloma; Nasopharyngeal Neoplasms; Osteosarcoma; Pancreatic Neoplasms; Paraganglioma; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Skin Neoplasms; Small Cell Lung Carcinoma; Thymoma; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colonic Neoplasms; Lymphoma, Large B-Cell, Diffuse; Ovarian Neoplasms; Stomach Neoplasms; Urogenital Neoplasms; Carcinoma, Merkel Cell; Carcinoma, Transitional Cell; Neoplasms; Neuroendocrine Tumors

Programmed cell death 1 ligand 1 other


Antibody Approved Unknown INJECTION Scleroderma, Systemic; Arthritis, Rheumatoid; Asthma; Crohn Disease; Hidradenitis Suppurativa; Arthritis, Psoriatic; Spondylitis, Ankylosing; Immune System Diseases; Psoriasis Interleukin-17 receptor A antagonist